CVS Health stock sheds 1.44% and underperforms competitors
Updated
Updated · MarketWatch · May 1
CVS Health stock sheds 1.44% and underperforms competitors
12 articles · Updated · MarketWatch · May 1
The shares closed at $82.09 on Friday, as the S&P 500 rose 0.29% to 7,230.12 and the Dow Jones Industrial Average slipped 0.31% to 49,499.27.
It was CVS's second straight daily loss, leaving the stock 3.59% below its 52-week high of $85.15 reached on 29 October.
CVS lagged Amazon, whose shares rose 1.21%, while UnitedHealth fell 0.46% and Elevance dropped 0.99%; trading volume of 4.9 million was well below its 50-day average of 7.8 million.
With looming regulatory threats and a shrinking store footprint, can CVS’s pharmacy-only strategy reignite growth or will it accelerate market share loss to rivals like Amazon?
How might the Tennessee PBM-pharmacy ownership ban reshape CVS’s national operations if similar laws spread, and what does this mean for patient care access?